Clinical trials
Phase 2/3 Primary Myelofibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2012 | 1 |
| 2019 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gruppo Italiano Trapianto di Midollo Osseo | 1 |
| Kartos Therapeutics, Inc. | 1 |
| M.D. Anderson Cancer Center | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| Roswell Park Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Primary Myelofibrosis | 5 |
| Anemia, Refractory, with Excess of Blasts | 2 |
| Blast Crisis | 2 |
| Leukemia, Myeloid, Accelerated Phase | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Leukemia, Myeloid, Chronic-Phase | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Anemia, Aplastic | 1 |
| Anemia, Refractory | 1 |
| Burkitt Lymphoma | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.